Among over 17,000 patients, the more selective enoxaparin protocol was associated with a reduction in wound hematomas compared with the original standard protocol (0.3% vs 0.7%; adjusted OR 0.38, 95% ...
Dec. 22, 2004 — The U.S. Food and Drug Administration (FDA) approved in October revisions to drug safety labeling to advise healthcare professionals of the following changes: use of the multidose ...
BACKGROUND: Venous thromboembolism (VTE) is a serious health care issue that affects a large number of people. Few standards exist for delineating the optimal dosing strategy for VTE prevention in ...
(RTTNews) - Sandoz, Inc., an unit of Novartis Pharma AG, is recalling one lot of deep vein thrombosis (DVT) medication Enoxaparin Sodium in the form of injection for the potential exposure to high ...
Sandoz is the first company to receive US approval to market a more affordable generic version of the leading hospital-based medication in the US US 2009 sales of Lovenox® were USD 2.7 billion ...
Patients exposed to a higher dose may be subject to bleeding complications. Apotex Corp announced the voluntary recall of 2 batches of Enoxaparin Sodium Injection ...
CHICAGO--(BUSINESS WIRE)--Meitheal Pharmaceuticals, Inc. (“Meitheal”), a fully integrated generic injectables company today announced the launch of Enoxaparin Sodium Injection, USP, the generic ...
Techdow USA is introducing 30 mg, 40 mg, 60 mg, 80 mg, 100 mg, 120 mg and 150 mg strengths of generic Enoxaparin Sodium (Preservative Free) Prefilled Syringes, which is the generic of Sanofi-Aventis’ ...
Lovenox (enoxaparin) is a prescription drug used to prevent or treat certain types of blood clots. Lovenox’s cost may depend on factors such as your dosage, whether you have health insurance, and how ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback